Approvals/TGA/EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle

Approved

STANDARD

EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1c39b8e970113ec9
Product Name: EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle
Artg Id: 176537
Artg Name: EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2012-01-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/bff2991cee38e36a73a4b38a7d4be5fb.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/edcda25ea9590b8cce01e952feecf6f3.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

1c39b8e970113ec9

Type

Standard